Hungary vs Indonesia: Previously treated cases tested for RR-/MDR-TB
Hungary
83.0%
in 2024
Indonesia
83.0%
in 2024
Hungary rank
104th
Indonesia rank
104th
Previously treated cases tested for RR-/MDR-TB over time
- Hungary
- Indonesia
How they compare
Hungary currently reports 83.0% against 83.0% in Indonesia, a difference of 0.0%.
The two have swapped places 5 times across 15 shared years of data; in 2010 it was Hungary ahead.
Hungary ranks 104th and Indonesia ranks 104th of 180 countries.
Indonesia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Hungary | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 47.8% | 63.3% | 15.5% | Indonesia |
| 2020s | 78.8% | 84.4% | 5.6% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Hungary or Indonesia?
- Hungary, at 83.0% against 83.0% in Indonesia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Hungary and Indonesia?
- 0.0%, with Hungary ahead.
- How many years of comparable data are there for Hungary and Indonesia?
- 15 years are reported by both, from 2010 to 2024.
- How do Hungary and Indonesia rank globally for previously treated cases tested for rr-/mdr-tb?
- Hungary ranks 104th and Indonesia ranks 104th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.